Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma.
Hematology (Amsterdam, Netherlands)（2023）
摘要
IRd could be a preferable treatment option for many patients with RRMM, particularly those seeking an efficacious and convenient therapeutic option.
更多查看译文
关键词
Network meta-analysis,dexamethasone,efficacy,ixazomib,lenalidomide,relapsed/refractory multiple myeloma,systematic literature review
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要